Suppr超能文献

用于治疗胱氨酸病眼科并发症的凝胶制剂。

Gel formulations for treatment of the ophthalmic complications in cystinosis.

机构信息

School of Pharmacy and Life Sciences, The Robert Gordon University, Schoolhill, Aberdeen, UK.

出版信息

Int J Pharm. 2010 Jun 15;392(1-2):192-7. doi: 10.1016/j.ijpharm.2010.03.065. Epub 2010 Apr 9.

Abstract

Nephropathic cystinosis is a rare autosomal recessive disease characterised by raised lysosomal levels of cystine in the cells of all organs. It is treated by regular administration of the aminothiol, cysteamine. Corneal crystal deposition is one of the most troublesome complications affecting patients and requires the hourly administration of cysteamine eye drops. In an attempt to reduce this frequency and improve the treatment, the preparation and evaluation of cysteamine containing Carbomer gel is reported. The results demonstrated that a weak gel network was formed at low shear-stress, the bioadhesion of the gel was increased with inclusion of a cysteamine derivative (e.g. mean force of 0.067N compared to 0.107N with compound included) and first-order release from the gel was observed. In conclusion these results offer the possibility to formulate cysteamine in an ocular applicable gel formulation.

摘要

遗传性胱氨酸病是一种罕见的常染色体隐性疾病,其特征是所有器官的细胞中溶酶体胱氨酸水平升高。该病通过定期给予氨基硫醇类药物半胱胺进行治疗。角膜晶体沉积是影响患者的最麻烦的并发症之一,需要每小时滴注半胱胺眼药水。为了减少这种频率并改善治疗效果,报道了含有卡波姆的半胱胺凝胶的制备和评价。结果表明,在低剪切应力下形成弱凝胶网络,包含半胱胺衍生物(例如,平均力为 0.067N,而包含化合物时为 0.107N)可增加凝胶的生物黏附性,并且观察到从凝胶中呈一级释放。总之,这些结果为将半胱胺制成眼用可应用凝胶制剂提供了可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验